Sign in

CIK 0001631574

  • Large accelerated filer

Wave Life Sciences, Inc.

Sign in to watch
Ticker
WVE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 617-949-2900
Business address
733 CONCORD AVENUE, CAMBRIDGE, MA, 02138
Former names
Wave Life Sciences Ltd., Wave Life Sciences LTD., WAVE Life Sciences Ltd., Wave Life Sciences Pte Ltd
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 45 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-02-09 Moran Kyle Chief Financial Officer Sale −3,588 $13.45 $48K 134,385
2026-02-05 Moran Kyle Chief Financial Officer Grant or award +45,625 137,973
2026-02-05 Moran Kyle Chief Financial Officer Grant or award · Share Option (right to buy) +273,750 273,750
2025-12-09 Moran Kyle Chief Financial Officer Exercise or conversion 10b5-1 +36,000 $8.17 $294K 125,218
2025-12-09 Moran Kyle Chief Financial Officer Sale 10b5-1 −36 $20.25 $729 89,218
2025-12-09 Moran Kyle Chief Financial Officer Exercise or conversion 10b5-1 +50,000 $10.48 $524K 139,218
2025-12-09 Moran Kyle Chief Financial Officer Sale 10b5-1 −50,000 $20.03 $1.0M 90,365
2025-12-09 Moran Kyle Chief Financial Officer Grant or award · Share Option (right to buy) 10b5-1 −36,000 0
2025-12-09 Moran Kyle Chief Financial Officer Grant or award · Share Option (right to buy) 10b5-1 −50,000 0
2025-12-08 Moran Kyle Chief Financial Officer Exercise or conversion 10b5-1 +60,000 $2.83 $170K 149,218
2025-12-08 Moran Kyle Chief Financial Officer Sale 10b5-1 −60,000 $13.20 $792K 89,218
2025-12-08 Moran Kyle Chief Financial Officer Exercise or conversion 10b5-1 +100,000 $3.14 $314K 189,218
2025-12-08 Moran Kyle Chief Financial Officer Sale 10b5-1 −50,000 $15.00 $750K 139,218
2025-12-08 Moran Kyle Chief Financial Officer Sale 10b5-1 −50,000 $13.20 $660K 89,218
2025-12-08 Moran Kyle Chief Financial Officer Exercise or conversion 10b5-1 +50,000 $4.75 $238K 139,218
2025-12-08 Moran Kyle Chief Financial Officer Sale 10b5-1 −50,000 $18.00 $900K 89,218
2025-12-08 Moran Kyle Chief Financial Officer Grant or award · Share Option (right to buy) 10b5-1 −60,000 0
2025-12-08 Moran Kyle Chief Financial Officer Grant or award · Share Option (right to buy) 10b5-1 −100,000 75,000
2025-12-08 Moran Kyle Chief Financial Officer Grant or award · Share Option (right to buy) 10b5-1 −50,000 222,700
2025-02-04 Moran Kyle Chief Financial Officer Grant or award +42,000 89,218

Page 1 of 2 · 39 trades